Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Winer

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Clinical Advances in Hematology & Oncology : H&O|September 30, 2008
The optimal duration of adjuvant hormonal therapy for early-stage breast cancerEric Winer
Cancer Discovery|August 10, 2013
Q&A: Eric Winer on neoadjuvant clinical trialsEric Winer
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2023
Rekindling Joy in Medicine Through Thoughtful Communication: A Practical GuideTara Sanft, Eric Winer
JAMA Oncology|May 8, 2020
De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ-ReplyMonica Morrow, Eric Winer
Experimental Hematology|June 21, 2008
Newer monoclonal antibodies for hematological malignanciesJorge Castillo, Eric Winer, Peter Quesenberry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directionsJulie R Gralow, Jo Anne Zujewski, Eric Winer
Cancer|February 28, 2007
Association between pharmaceutical involvement and outcomes in breast cancer clinical trialsJeffrey Peppercorn, Emily Blood, Eric Winer, et al.
Nature Reviews. Clinical Oncology|September 30, 2010
Triple-negative breast cancer: disease entity or title of convenience?Lisa Carey, Eric Winer, Giuseppe Viale, et al.
Journal of the National Cancer Institute|January 1, 2016
ResponseJennifer A Ligibel, Eric Winer, Clifford A Hudis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Self-reported practices and attitudes of US oncologists regarding off-protocol therapyJeffrey Peppercorn, Harold Burstein, Franklin G Miller, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Clinical Advances in Hematology & Oncology : H&O|September 30, 2008
The optimal duration of adjuvant hormonal therapy for early-stage breast cancerEric Winer
Cancer Discovery|August 10, 2013
Q&A: Eric Winer on neoadjuvant clinical trialsEric Winer
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2023
Rekindling Joy in Medicine Through Thoughtful Communication: A Practical GuideTara Sanft, Eric Winer
JAMA Oncology|May 8, 2020
De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ-ReplyMonica Morrow, Eric Winer
Experimental Hematology|June 21, 2008
Newer monoclonal antibodies for hematological malignanciesJorge Castillo, Eric Winer, Peter Quesenberry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directionsJulie R Gralow, Jo Anne Zujewski, Eric Winer
Cancer|February 28, 2007
Association between pharmaceutical involvement and outcomes in breast cancer clinical trialsJeffrey Peppercorn, Emily Blood, Eric Winer, et al.
Nature Reviews. Clinical Oncology|September 30, 2010
Triple-negative breast cancer: disease entity or title of convenience?Lisa Carey, Eric Winer, Giuseppe Viale, et al.
Journal of the National Cancer Institute|January 1, 2016
ResponseJennifer A Ligibel, Eric Winer, Clifford A Hudis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Self-reported practices and attitudes of US oncologists regarding off-protocol therapyJeffrey Peppercorn, Harold Burstein, Franklin G Miller, et al.
Pageof 11